5 companies in 4 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1โ25 of 38
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BUPRENEX0.3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท Injectable | Buprenorphine | United States | Not marketed | 1981 |
| OPVEE2.7mg base/spray ยท Spray | Nalmefene | United States | Marketed | 2023 |
| PERSERIS KIT120mg | 90mg ยท For suspension, extended release | Risperidone | United States | Marketed | 2018 |
| SUBLOCADE100mg/0.5ml (100mg/0.5ml) | 300mg/1.5ml (200mg/ml) ยท Solution, extended release | Buprenorphine | United States | Marketed | 2017 |
| SUBLOCADE100 mg / 0.5 ml ยท Solution (Extended-Release) | Buprenorphine | Canada | Marketed | 2020 |
| SUBLOCADE300 mg / 1.5 ml ยท Solution (Extended-Release) | Buprenorphine | Canada | Marketed | 2020 |
| SUBOXONE2 mg + 0.5 mg ยท Tablet | Buprenorphine, Naloxone | Canada | Marketed | 2007 |
| SUBOXONE8 mg + 2 mg ยท Tablet | Buprenorphine, Naloxone | Canada | Marketed | 2007 |
| SUBOXONE16 mg + 4 mg ยท Tablet | Buprenorphine, Naloxone | Canada | Marketed | 2018 |
| Suboxone | Buprenorphine, Naloxone | EU (EMA) | Authorised | 2006 |
| SUBOXONE12mg base; 3mg base | 2mg base; 0.5mg base | 4mg base; 1mg base | 8mg base; 2mg base ยท Film | Buprenorphine, Naloxone | United States | Marketed | 2010 |
| SUBOXONE2 mg + 0.5 mg ยท Film (Soluble) | Buprenorphine, Naloxone | Canada | Marketed | 2021 |
| SUBOXONE12 mg + 3 mg ยท Film (Soluble) | Buprenorphine, Naloxone | Canada | Marketed | 2021 |
| SUBOXONE12 mg + 3 mg ยท Tablet | Buprenorphine, Naloxone | Canada | Marketed | 2018 |
| SUBOXONE2MG BASE; 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 8MG BASE; 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท Tablet | Buprenorphine, Naloxone | United States | Not marketed | 2002 |
| SUBOXONE8 mg + 2 mg ยท Film (Soluble) | Buprenorphine, Naloxone | Canada | Marketed | 2021 |
| SUBOXONE4 mg + 1 mg ยท Film (Soluble) | Buprenorphine, Naloxone | Canada | Marketed | 2021 |
| Suboxone 12 mg/3 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine, Naloxone | Netherlands | Authorised | 2020 |
| SUBOXONE 12 MG/3 MG PELICULA SUBLINGUAL12,96 mg + 3,66 mg ยท Pelicula sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2020 |
| SUBOXONE 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES2 mg + 0,5 mg ยท Comprimido sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2014 |
| SUBOXONE 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES2 mg + 0,5 mg ยท Comprimido sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2006 |
| Suboxone 2 mg/0.5 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine, Naloxone | Netherlands | Authorised | 2020 |
| SUBOXONE 2 MG/0,5 MG PELICULA SUBLINGUAL2,16 mg + 0,61 mg ยท Pelicula sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2020 |
| Suboxone 4 mg/1 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine, Naloxone | Netherlands | Authorised | 2020 |
| SUBOXONE 4 MG/1 MG PELICULA SUBLINGUAL4,32 mg + 1,22 mg ยท Pelicula sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2020 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 10 | 10 | 0 | CompaniesAll medicines |
| Spain | 8 | 8 | 0 | CompaniesAll medicines |
| Netherlands | 7 | 7 | 0 | CompaniesAll medicines |
| United States | 7 | 7 | 0 | CompaniesAll medicines |
| Croatia | 3 | 3 | 0 | CompaniesAll medicines |
| Romania | 2 | 0 | 2 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Colombia, France, Italy, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65f44e8ef5609e7c932fe/List_of_Terminated__Cancelled_and_Revoked_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:19.029217+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA published licence history
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep Indiviorโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
